Finally, we recognize that the present study has several limitations, such as: (i) the small GDM population recruited, (ii) the absence of S100B correlation with longitudinal glucose monitoring and insulin treatment [41], and (iii) long term follow-up. This evidence concerns the gene S100B and gestational diabetes.